Intellectual Property Licensing

Aurora Biotechnologies’ intellectual property portfolio includes:

7,270,784 - NanoScreen®. Automated Laboratory for High Throughput Biological Assays and RNA Interference describes processes and methods to miniaturize at > 384 (1536 and above) various biological processes including high throughput, high content cell imaging/screening, molecular biology, RNA interference and cell gene expression and other biological processes. 

These microplate products and the processes Aurora has developed to perform ultrahigh throughput drug discovery or biological screening are covered by one or more of the following US Patents and patent applications, as well corresponding pending or issued foreign patents: 7,270,784; 6,861,035; 6,825,042; 6,730,520; 6,517,781; 6,514,464; 6,503,456; 6,426,050; D454,202; 6,254,833; 6,232,114; 6,229,603; 6,171,780; D428,157; 6,063,338; 5,910,287; 20050214174; 20050048575; 20050019221; 20040202582; 20030039592, 20030039591, 20020155617; 20020074689

Made in U.S.A. in Carlsbad, California and Scottsdale, Arizona.

These patents provide Aurora Biotechnologies with a clear FTO to make, use and sell these unique microplate products. Additional patent pending will further protect the Company’s proprietary products with features such as an evaporation barriers that virtually eliminate "edge effects", unique designs for acoustic dispensing and preprinted single-use chemicals/biologicals that are ready-to-use in COP microplates branded contentPlate™.

For more information please contact Charles Powell at cpowell@aurorabiotechnologies.com

Trade Marks
The following trade marks are the sole property of Aurora Biotechnologies:
Stylized Aurora (see above)
Aurora Discovery®
Aurora Biosciences®
Aurora Biotechnologies®
Aurora Bio®
NanoPlate®
NanoWell®
NanoScreen®
MaKO™
ContentPlate™
ChemLib™